However, we did not see activation of PKC-δ by TGF-β in IPF lung fibroblasts, suggesting a more prominent role possibly for inhibition of Akt by active site mTOR inhibitors, not PKC-δ, in the inhibition of fibroblast activation and lung fibrosis. This evidence concerns the gene PRKCD and pulmonary fibrosis.